# WELIREG
> **NDA215383** · New Drug Application · Sponsor: MERCK SHARP DOHME · Approved 2021-08-13
## Drug
- **FDA Application Number:** NDA215383
- **Application type:** New Drug Application
- **Brand name:** WELIREG
- **Generic name:** BELZUTIFAN
- **Active ingredients:** BELZUTIFAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MERCK SHARP DOHME
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2021-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215383)
---
*AI Analytics · CC0 1.0*